cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ventyx Biosciences Inc
4 own
2 watching
Current Price
$4.47
$0.12
(2.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,076.73M
52-Week High
52-Week High
40.58000
52-Week Low
52-Week Low
1.86500
Average Volume
Average Volume
0.9M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,076.73M
icon52-Week High40.58000
icon52-Week Low1.86500
iconAverage Volume0.9M
iconDividend Yield--
iconP/E Ratio--
What does the Ventyx Biosciences Inc do?
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company s lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
Read More
How much money does Ventyx Biosciences Inc make?
News & Events about Ventyx Biosciences Inc.
Fool.com Headlines
9 months ago
The company has several promising autoimmune therapies.On Monday, shares of Ventyx Biosciences (NASDAQ: VTYX) closed 22.87% higher than they did last week. The clinical-stage biotech hit more than $40 a share for the first time since March 10.Ventyx focuses on therapies to treat inflammatory ...
Zolmax
10 months ago
Ventyx Biosciences, Inc. (NASDAQ:VTYX Get Rating) insider William J. Sandborn sold 3,487 shares of the firms stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.15, for a total value of $119,081.05. Following the transaction, the ...
Ticker Report
1 year ago
Ventyx Biosciences (NASDAQ:VTYX Get Rating) had its price target trimmed by Oppenheimer from $65.00 to $62.00 in a research report report published on Friday, Benzinga reports. The brokerage currently has an outperform rating on the stock. Oppenheimer also issued estimates for Ventyx ...
Ticker Report
1 year ago
Ventyx Biosciences, Inc. (NASDAQ:VTYX Get Rating) Stock analysts at Oppenheimer issued their FY2026 EPS estimates for shares of Ventyx Biosciences in a report issued on Sunday, March 19th. Oppenheimer analyst J. Jones forecasts that the company will post earnings per share of ($2.75...
Globe Newswire
1 year ago
ENCINITAS, Calif., March 24, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (Ventyx), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that ...
Frequently Asked Questions
Frequently Asked Questions
What is Ventyx Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Ventyx Biosciences Inc shares?
plus_minus_icon
How can I buy Ventyx Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Ventyx Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ventyx Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Ventyx Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Ventyx Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ventyx Biosciences Inc?
plus_minus_icon
What percentage is Ventyx Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ventyx Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.47
$0.12
(2.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00